Literature DB >> 23730314

Control of Clostridium difficile-associated diarrhea by antibiotic stewardship in a small community hospital.

Alice Schabas1, David N Fisman, Richard Schabas.   

Abstract

Entities:  

Year:  2012        PMID： 23730314      PMCID： PMC3403666          DOI： 10.1155/2012/358059

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  7 in total

1.  Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec.

Authors:  Jacques Pépin; Louis Valiquette; Benoit Cossette
Journal:  CMAJ       Date:  2005-09-22       Impact factor: 8.262

2.  Treatment of community-acquired pneumonia.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 3.  New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.

Authors:  Herbert L DuPont; Kevin Garey; Juan-Pablo Caeiro; Zhi-Dong Jiang
Journal:  Curr Opin Infect Dis       Date:  2008-10       Impact factor: 4.915

4.  Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.

Authors:  Annie-Claude Labbé; Louise Poirier; Duncan Maccannell; Thomas Louie; Michel Savoie; Claire Béliveau; Michel Laverdière; Jacques Pépin
Journal:  Antimicrob Agents Chemother       Date:  2008-06-23       Impact factor: 5.191

Review 5.  Infection control measures to limit the spread of Clostridium difficile.

Authors:  R-P Vonberg; E J Kuijper; M H Wilcox; F Barbut; P Tüll; P Gastmeier; P J van den Broek; A Colville; B Coignard; T Daha; S Debast; B I Duerden; S van den Hof; T van der Kooi; H J H Maarleveld; E Nagy; D W Notermans; J O'Driscoll; B Patel; S Stone; C Wiuff
Journal:  Clin Microbiol Infect       Date:  2008-05       Impact factor: 8.067

6.  Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Severe pseudomembranous colitis after moxifloxacin use: a case series.

Authors:  Jason C Gallagher; Jennifer K Du; Christina Rose
Journal:  Ann Pharmacother       Date:  2008-12-09       Impact factor: 3.154
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.